Abstract:Intestinal microecology includes intestinal microorganisms and their metabolites. Intestinal microecology has complex mechanisms of action, is widely distributed and includes a large number of species in the human body. With the development and application of biological research techniques and analytical methods, our understanding of intestinal microecology has gradually improved. Clostridium difficile infection (CDI) is closely related to the dysbiosis of intestinal microflora and is mutually causal. CDI treatments are urgently needed. This article reviews CDI pathogenesis, risk factors and treatments, and describes related research progress in gastrointestinal microecology. This article aims to increase understanding of intestinal microecology and CDI, and improve CDI clinical diagnosis, treatment and prevention.
王晓亚, 安彦波, 戴敏高, 赵丽娜, 刘军肖, 牛占丛. 艰难梭菌感染与肠道微生态的研究进展[J]. 中国人兽共患病学报, 2021, 37(9): 833-838.
WANG Xiao-ya, AN Yan-bo, DAI Min-gao, ZHAO Li-na, LIU Jun-xiao, NIU Zhan-cong. Research progress in Clostridium difficile infection and gastrointestinal microecology. Chinese Journal of Zoonoses, 2021, 37(9): 833-838.
[1] 程敬伟,刘文恩,马小军,等.中国成人艰难梭菌感染诊断和治疗专家共识[J]. 协和医学杂志,2017,8(Z1):131-138. [2] 顾思岚. 基于高通量测序和代谢组学的艰难梭菌感染患者肠道微生态研究[D]. 杭州:浙江大学,2016. [3] Burke KE, Lamont JT.Clostridium difficile infection: a worldwide disease[J]. Gut liver,2014,8(1):1-6. DOI:10.5009/gnl.2014.8.1.1 [4] Elliott B, Dingle KE, Didelot X, et al.The complexity and diversity of the pathogenicity locus in Clostridium difficile clade 5[J]. Genome Biol Evol,2014,6(12):3159-3170. DOI:10.1093/gbe/evu248 [5] 中国艰难梭菌医院感染预防与控制指南[J]. 中华医院感染学杂志,2018,28(23):3674-3680. [6] Carter GP, Douce GR, Govind R, et al.The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile[J]. PLoS Pathog, 2011,7(10):e1002317. DOI:10.1371/journal.ppat.1002317 [7] Dubberke ER, Olsen MA.Burden of Clostridium difficile on the healthcare system[J]. Clin Infect Dis,2012,55(suppl_2):S88-92. DOI:10.1093/cid/cis335 [8] Sender R, Fuchs S, Milo R.Revised estimates for the number of human and bacteria cells in the body[J]. PLoS Biol,2016,14(8):e1002533. DOI:10.1371/journal.pbio.1002533 [9] Fukuda S, Toh H, Hase K, et al.Bifidobacteria can protect from enteropathogenic infection through production of acetate[J]. Nature,2011,469(7331):543-547.DOI:10.1038/nature09646 [10] Kabat AM, Srinivasan N, Maloy KJ.Modulation of immune development and function by intestinal microbiota[J]. Trends Immunol,2014,35(11):507-517.DOI:10.1016/j.it.2014.07.010 [11] Carding S, Verbeke K, Vipond DT, et al.Dysbiosis of the gut microbiota in disease[J]. Microb Ecol Health Dis,2015,26:26191. DOI:10.3402/mehd.v26.26191 [12] Forsythe P, Kunze W, Bienenstock J.Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis[J]. BMC Med,2016,14(1):58.DOI:10.1186/s12916-016-0604-8 [13] Long-Smith C, O’Riordan KJ, Clarke G, et al. Microbiota-gut-brain axis: new therapeutic opportunities[J]. Ann Rev Pharmacol Toxicol,2020,60(1):477-502.DOI:10.1146/annurev-pharmtox-010919-023628 [14] Lyras D, O’connor JR, Howarth PM, et al.Toxin B is essential for virulence of Clostridium difficile[J]. Nature,2009,458(7242):1176-1179.DOI:10.1038/nature07822 [15] Tinoco-Veras CM, Santos AAQA, Stipursky J, et al.Transforming growth factor β1/SMAD signaling pathway activation protects the intestinal epithelium from Clostridium difficile toxin a-induced damage[J]. Infect Immun,2017,85(10):e00430-17. DOI:10.1128/IAI.00430-17 [16] Carter GP, Chakravorty A, Nguyen TAP, et al.Defining the roles of TcdA and TcdB in localized gastrointestinal disease, systemic organ damage, and the host response during Clostridium difficile infections[J]. mBio,2015,6(3):e00551.DOI:10.1128/mBio.00551-15 [17] Kelly CP, Kyne L.The host immune response to Clostridium difficile[J]. J Med Microbiol,2011,60(8):1070-1079.DOI:10.1099/jmm.0.030015-0 [18] Pengfei Y, Hongmin Z, Changzu C, et al.Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B[J]. Cell Res,2015,25(2):157-168.DOI:10.1038/cr.2014.169 [19] 罗雨欣,韩菲,张瑞苗,等. 艰难梭菌感染的流行病学及危险因素[J]. 临床荟萃,2018,33(5):369-372. [20] O’Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain[J]. Gastroenterology,2009,136(6):1913-1924.DOI:10.1053/j.gastro.2009.02.073 [21] Gupta P, Yakubov S, Tin K, et al.Does alkaline colonic pH predispose to Clostridium difficile infection[J]. South Med J,2016,109(2):91-96.DOI:10.14423/SMJ.0000000000000414 [22] Theriot CM, Koenigsknecht MJ, Carlson PE, et al.Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection[J]. Nat Commun, 2014,5(1):3114.DOI:10.1038/ncomms4114 [23] Davies K, Lawrence J, Berry C, et al.Risk factors for primary Clostridium difficile infection; results from the observational study of risk factors for Clostridium difficile infection in hospitalized patients with infective diarrhea (ORCHID)[J]. Front Public Health,2020,8:293.DOI:10.3389/fpubh.2020.00293 [24] Carlos Q, Tatiana M, Grettel A, et al.Proteogenomic analysis of the Clostridium difficile exoproteome reveals a correlation between phylogenetic distribution and virulence potential[J]. Anaerobe, 2020,62:102151. DOI:10.1016/j.anaerobe.2020.102151 [25] Brown KA, Nagham K, Nick D, et al.Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection[J]. Antimicrob Agents Chemother,2013,57(5):2326-2332.DOI:10.1093/jac/dkt129 [26] Lemon KP, Armitage GC, Relman DA, et al.Microbiota-targeted therapies: an ecological perspective[J]. Sci Transl Med,2012,4(137):135-137.DOI:10.1126/scitranslmed.3004183 [27] Watson T, Hickok J, Fraker S, et al.Evaluating the risk factors for hospital-onset Clostridium difficile infections in a large healthcare system[J]. Clin Infect Dis, 2018,66(12):1957-1959. DOI:10.1093/cid/cix1112/4767819 [28] Migriauli I, Meunargia V, Chkhaidze I, et al.Factors affecting development of Clostridium difficile infection in hospitalized pediatric patients in the country Georgia[J]. BMC Res Notes,2018,11(1):409.DOI:10.1186/s13104-018-3517-0 [29] Teng C, Reveles KR, Obodozie-Ofoegbu OO, et al.Clostridium difficile infection risk with important antibiotic classes: an analysis of the FDA adverse event reporting system[J]. Int J Med Sci,2019,16(5):630-635.DOI:10.7150/ijms.30739 [30] 李子艳,刘丽丽,毛艳艳,等.抗生素与肠道菌群关系研究进展[J]. 科技导报,2017,35(21):26-31. [31] Ferreyra JA, Wu KJ, Hryckowian AJ, et al.Gut microbiota-produced succinate promotes C.difficile infection after antibiotic treatment or motility disturbance[J]. Cell Host Microbe,2014,16(6):770-777. DOI:10.1016/j.chom.2014.11.003 [32] Jenior ML, Leslie JL, Young VB, et al. Clostridium difficile colonizes alternative nutrient niches during infection across distinct murine gut microbiomes[J]. mSystems,2017,2(4):e00063-17-e00063-17. DOI:10.1128/mSystems.00063-17 [33] Allen SJ.The potential of probiotics to prevent Clostridium difficile infection[J]. Infect Dis Clin North Am,2015,29(1):135-144.DOI:10.1016/j.idc.2014.11.002 [34] Dinh A, Le Monnier A, Emery C, et al.Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study[J]. Eur J Clin Microbiol Infect Dis,2019,38(7):1297-1305.DOI:10.1007/s10096-019-03552-9 [35] Chopra T, Awali RA, Biedron C, et al.Predictors of Clostridium difficile infection-related mortality among older adults[J]. Am J Infect Control,2016,44(11):1219-1223.DOI:10.1016/j.ajic.2016.04.231 [36] Azab M, Doo L, Doo DH, et al.Comparison of the hospital-acquired Clostridium difficile infection risk of using proton pump inhibitors versus histamine-2 receptor antagonists for prophylaxis and treatment of stress ulcers: a systematic review and meta-analysis[J]. Gut Liver,2017,11(6):781-788.DOI:10.5009/gnl16568 [37] Park YH, Seong JM, Cho S, et al.Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study[J]. J Gastroenterol,2019,54(12):1052-1060.DOI:10.1007/s00535-019-01598-2 [38] Antharam VC, Li EC, Ishmael A, et al.Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea[J]. J Clin Microbiol,2013,51(9):2884-2892.DOI:10.1128/JCM.00845-13 [39] Anders HJ, Andersen K, Stecher B.The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease[J]. Kidney Int,2013,83(6):1010-1016.DOI:10.1038/ki.2012.440 [40] Macfarlane GT, Macfarlane S.Bacteria, colonic fermentation, and gastrointestinal health[J]. J AOAC Int,2012,95(1):50-60.DOI:10.5740/jaoacint.sge_macfarlane [41] Dai ZL, Wu G, Zhu WY.Amino acid metabolism in intestinal bacteria: links between gut ecology and host health[J]. Front Biosci (Landmark Ed),2011,16:1768-1786.DOI:10.2741/3820 [42] Obrenovich ME, Tima M, Polinkovsky A, et al.Targeted metabolomics analysis identifies intestinal microbiota-derived urinary biomarkers of colonization resistance in antibiotic-treated mice[J]. Antimicrob Agents Chemother,2017,61(8): e00477-17.DOI:10.1128/AAC.00477-17 [43] Vogt S L, Pena-Diaz J, Finlay BB.Chemical communication in the gut: Effects of microbiota-generated metabolites on gastrointestinal bacterial pathogens[J]. Anaerobe,2015,34:106-115. DOI:10.1016/j.anaerobe.2015.05.002 [44] Reichardt N, Duncan SH, Young P, et al.Phylogenetic distribution of three pathways for propionate production within the human gut microbiota[J]. ISME J,2014,8(6):1323-1335.DOI:10.1038/ismej.2014.14 [45] Theriot CM, Koenigsknecht MJ, Carlson PJ, et al.Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection[J]. Nat Commun,2014,5:3114. DOI:10.1038/ncomms4114 [46] Jump RLP, Polinkovsky A, Hurless K, et al.Metabolomics analysis identifies intestinal microbiota-derived biomarkers of colonization resistance in clindamycin-treated mice[J]. PLoS One,2014,9(7):e101267. DOI:10.1371/journal.pone.0101267 [47] Romano M, Tung SL, Smyth LA, et al.Treg therapy in transplantation: a general overview[J]. Transpl Int,2017,30(8):745-753.DOI:10.1111/tri.12909 [48] Zhang YS, Xin DE, Wang Z, et al.STAT4 activation by leukemia inhibitory factor confers a therapeutic effect on intestinal inflammation[J]. EMBO J,2019,38(6):1-20.DOI:10.15252/embj.201899595 [49] Chen Y, Chen I, Pham G, et al.IL-17-producing γδ T cells protect against Clostridium difficile infection[J]. J Clin Invest,2020,130(5):2377-2390.DOI:10.1172/JCI127242 [50] Bruxelle JF, Mizrahi A, Hoys S, et al.Immunogenic properties of the surface layer precursor of Clostridium difficile and vaccination assays in animal models[J]. Anaerobe,2016,37:78-84.DOI:10.1016/j.anaerobe.2015.10.010 [51] Crobach MJT, Planche T, Eckert C, et al.European society of clinical microbiology and infectious diseases: update of the diagnostic guidance document for Clostridium difficile infection[J]. Clin Microbiol Infect,2016,22:S63-S81.DOI:10.1016/j.cmi.2016.03.010 [52] Clifford ML, Gerding DN, Stuart J, et al.Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of america (IDSA) and society for healthcare epidemiology of america (SHEA)[J]. Clin Infect Dis, 2018, 66(7):987-994.DOI:10.1093/cid/ciy149 [53] van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile[J]. N Engl J Med,2013,368(5):407-415.DOI:10.1056/NEJMoa1205037 [54] Dembrovszky F, Gede N, Szakács Z, et al.Fecal microbiota transplantation may be the best option in treating multiple Clostridioides difficile infection: a network meta-analysis[J]. Infect Dis Ther,2021, 10(1):201-211.DOI:10.1007/s40121-020-00356-9 [55] Seekatz AM, Theriot CM, Rao K, et al.Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection[J]. Anaerobe,2018,53:64-73.DOI:10.1016/j.anaerobe.2018.04.001 [56] Weingarden AR, Chen C, Bobr A, et al.Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection[J]. Am J Physiol Gastrointestinal Liver Physiol,2014,306(4):G310-G319.DOI:10.1152/ajpgi.00282.2013 [57] Allegretti JR, Kearney S, Li N, et al.Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles[J]. Aliment Pharmacol Ther,2016,43(11):1142-1153.DOI:10.1111/apt.13616 [58] Shrestha R, Lockless SW, Sorg JA.A Clostridium difficile alanine racemase affects spore germination and accommodates serine as a substrate[J]. J Biolog Chem,2017,292(25):10735-10742. DOI:10.1074/jbc.M117.791749 [59] Lawes T, Lopez-Lozano J, Nebot CA, et al.Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis[J]. Lancet Infect Dis,2017,17(2):194-206.DOI:10.1016/S1473-3099(16)30397-8 [60] Kundrapu S, Sunkesula V, Jury I, et al.A randomized trial of soap and water hand wash versus alcohol hand rub for removal of Clostridium difficile spores from hands of patients[J]. Infect Control Hosp Epidemiol,2014,35(2):204-206.DOI:10.1086/674859 [61] Tschudin-Sutter S, Kuijper EJ, Durovic A, et al.Guidance document for prevention of Clostridium difficile infection in acute healthcare settings[J]. Clin Microbiol Infect,2018,24(10):1051-1054. DOI:10.1016/j.cmi.2018.02.020 [62] Shen NT, Maw A, Tmanova LL, et al.Timely use of probiotics in hospitalized adults prevents Clostridium difficile infection: a systematic review with meta-regression analysis[J]. Gastroenterology,2017,152(8):1889-1900.DOI:10.1053/j.gastro.2017.02.003 [63] 康颖. 水苏糖、多形拟杆菌对艰难梭菌定植和肠道微生态的影响[D]. 北京:中国疾病预防控制中心,2020.